Table 4.
Outcomes | I n (%) |
II/III n (%) |
p-Value |
---|---|---|---|
Symptomatic infection | 17 (81) | 20 (66) | 0.346 |
Neurological localized infection | 15 (75) | 12 (40) | 0.021 |
Auxological Impairment | 5 (28) | 4 (18) | 0.705 |
Neurodevelopmental impairment | 4 (23) | 2 (9) | 0.373 |
Hearing Loss | 7 (33) | 3 (12) | 0.149 |
Need for cochlear implant | 6 (28) | 0 | 0.003 |